TY - JOUR
T1 - Current status of site-specific cancer registry system for the clinical researches
T2 - aiming for future contribution by the assessment of present medical care
AU - Hirata, Koichi
AU - Imamura, Masafumi
AU - Fujiwara, Toshiyoshi
AU - Fukui, Tsuguya
AU - Furukawa, Toshiharu
AU - Gotoh, Mitsukazu
AU - Hakamada, Kenichi
AU - Ishiguro, Megumi
AU - Kakeji, Yoshihiro
AU - Konno, Hiroyuki
AU - Miyata, Hiroaki
AU - Mori, Masaki
AU - Okita, Kenji
AU - Sato, Masami
AU - Shibata, Akiko
AU - Takemasa, Ichiro
AU - Unno, Michiaki
AU - Yokoi, Kohei
AU - Nishidate, Toshihiko
AU - Nishiyama, Masahiko
N1 - Publisher Copyright:
© 2019, Japan Society of Clinical Oncology.
PY - 2019/9/13
Y1 - 2019/9/13
N2 - Background: The current status of site-specific cancer registry has not been elucidated, but sufficient system is found in some societies. The purpose of this study was to clear the present condition of site-specific cancer registries in Japan and to suggest for the improvement. Methods: The questionnaire was conducted by the study group of the Ministry of Health, Labor, and Welfare. It consisted of 38 questions, conflicts of interest, clinical research method, informed consent and funding for registry. We distributed this questionnaire to 28 academic societies, which had published the clinical practice guideline(s) assessed under Medical Information Network Distribution Service (MINDS). Results: The concept of the importance in assessment for medical quality by the data of the site-specific cancer registry was in good consensus. But the number of the society with the mature registry was limited. The whole-year registry with the scientific researches in the National Clinical Database (NCD) and in the Translational Research Informatics Center (TRI) might seem to be in success, because assured enhancement may be estimated. Now, academic societies have the structural factors, i.e., the financial limitation in the registry maintenance and the data analysis, and in the difficulty of employment of the researchers with skill and talent. Conclusions: To manage the site-specific cancer registry effectively, the scientific registry system will be essentially important. Each academic society had much experienced highly qualified clinical researches in past. Accordingly, the scientific suggestion and co-operation should be of great importance for the improvement.
AB - Background: The current status of site-specific cancer registry has not been elucidated, but sufficient system is found in some societies. The purpose of this study was to clear the present condition of site-specific cancer registries in Japan and to suggest for the improvement. Methods: The questionnaire was conducted by the study group of the Ministry of Health, Labor, and Welfare. It consisted of 38 questions, conflicts of interest, clinical research method, informed consent and funding for registry. We distributed this questionnaire to 28 academic societies, which had published the clinical practice guideline(s) assessed under Medical Information Network Distribution Service (MINDS). Results: The concept of the importance in assessment for medical quality by the data of the site-specific cancer registry was in good consensus. But the number of the society with the mature registry was limited. The whole-year registry with the scientific researches in the National Clinical Database (NCD) and in the Translational Research Informatics Center (TRI) might seem to be in success, because assured enhancement may be estimated. Now, academic societies have the structural factors, i.e., the financial limitation in the registry maintenance and the data analysis, and in the difficulty of employment of the researchers with skill and talent. Conclusions: To manage the site-specific cancer registry effectively, the scientific registry system will be essentially important. Each academic society had much experienced highly qualified clinical researches in past. Accordingly, the scientific suggestion and co-operation should be of great importance for the improvement.
KW - Assessment of medical quality
KW - Clinical research
KW - The site-specific cancer registry
UR - http://www.scopus.com/inward/record.url?scp=85064716064&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064716064&partnerID=8YFLogxK
U2 - 10.1007/s10147-019-01434-w
DO - 10.1007/s10147-019-01434-w
M3 - Article
C2 - 31011913
AN - SCOPUS:85064716064
SN - 1341-9625
VL - 24
SP - 1161
EP - 1168
JO - International Journal of Clinical Oncology
JF - International Journal of Clinical Oncology
IS - 9
ER -